Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy-MedSci.cn

Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy

Kou, F; Wu, L; Zhu, Y; Li, BH; Huang, ZQ; Ren, XB; Yang, LL

Ren, XB; Yang, LL (通讯作者)，Tianjin Med Univ Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China.;Ren, XB; Yang, LL (通讯作者)，Natl Clin Res Ctr Canc, Tianjin, Peoples R China.;Ren, XB; Yang, LL (通讯作者)，Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China.;Ren, XB; Yang, LL (通讯作者)，Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.;Ren, XB; Yang, LL (通讯作者)，Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.;Ren, XB (通讯作者)，Tianjin Med Univ Canc Inst & Hosp, Dept Biotherapy, Tianjin, P

Abstract

Somatic copy number alterations (SCNA), which are widespread in cancer, can predict the efficacy of immune checkpoint inhibitors in non-small-cell lun......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy

科室

工具

服务